Upstream Bio Ownership | Who Owns Upstream Bio?
Upstream Bio Ownership Summary
Upstream Bio is owned by 37.78% institutional investors, 14.77% insiders, and 47.45% retail investors. Fmr is the largest institutional shareholder, holding 15.04% of UPB shares.
UPB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Upstream Bio | 37.78% | 14.77% | 47.45% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 8.09M | 15.04% | $152.11M |
| Orbimed advisors | 5.69M | 10.59% | $107.10M |
| Blackrock funding, inc. /de | 3.34M | 6.20% | $90.80M |
| Decheng capital | 3.14M | 5.83% | $85.33M |
| Norges bank | 2.88M | 5.35% | $78.26M |
| Enavate sciences gp | 2.46M | 4.57% | $46.27M |
| Bain capital life sciences investors | 2.44M | 4.54% | $45.89M |
| Vanguard group | 2.39M | 4.43% | $64.85M |
| Tcg crossover management | 2.12M | 3.94% | $39.82M |
| Ubs group | 1.81M | 3.35% | $49.04M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Enavate sciences gp | 2.46M | 14.13% | $46.27M |
| Decheng capital | 3.14M | 11.48% | $85.33M |
| Omega fund management | 1.36M | 11.47% | $25.51M |
| Bain capital life sciences investors | 2.44M | 3.05% | $45.89M |
| Orbimed advisors | 5.69M | 2.52% | $107.10M |
| Samsara biocapital | 962.15K | 2.36% | $18.10M |
| Great point partners | 300.00K | 2.33% | $5.64M |
| Tcg crossover management | 2.12M | 1.96% | $39.82M |
| Parkman healthcare partners | 843.50K | 1.66% | $15.87M |
| Vr adviser | 1.17M | 1.24% | $21.99M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 2.88M | 0.01% | 2.88M |
| Ubs group | 1.81M | 0.01% | 1.53M |
| Pictet asset management sa | 773.15K | 0.02% | 773.15K |
| Blackrock funding, inc. /de | 3.34M | 0.00% | 740.80K |
| State street | 1.11M | 0.00% | 633.21K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Altshuler shaham | 1.42M | 0.44% | -1.98M |
| Deep track capital, lp | - | - | -1.44M |
| Vr adviser | 1.17M | 1.24% | -1.13M |
| Tcg crossover management | 2.12M | 1.96% | -684.66K |
| Omega fund management | 1.36M | 11.47% | -680.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 2.88M | 0.01% | 2.88M | $78.26M |
| Pictet asset management sa | 773.15K | 0.02% | 773.15K | $20.99M |
| Integral health asset management | 575.00K | 0.73% | 575.00K | $10.82M |
| Jennison associates | 288.85K | 0.00% | 288.85K | $7.84M |
| Ikarian capital | 161.11K | 0.31% | 161.11K | $3.03M |
Sold Out
| Holder | Change |
|---|---|
| Principal securities | -12.00 |
| True wealth design | -31.00 |
| Advisor group | -42.00 |
| Physician wealth advisors | -69.00 |
| Clearstead advisors | -163.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 74 | -26.73% | 20,373,646 | -54.18% | 37 | 0.55% | 51 | -22.73% | 18 | -10.00% |
| Sep 30, 2025 | 97 | 24.36% | 42,344,528 | -12.14% | 78 | 0.98% | 63 | 21.15% | 19 | 58.33% |
| Jun 30, 2025 | 82 | 6.49% | 48,353,677 | 6.86% | 89 | 1.26% | 55 | -28.57% | 13 | - |
| Mar 31, 2025 | 77 | - | 45,306,251 | - | 84 | - | 77 | - | - | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
UPB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools